chronic

Showing 2 posts of 2 posts found.

Amgen, Novartis migraine drug meets primary endpoint in Phase II study

June 9, 2016
Research and Development AMG 334, Amgen, Novartis, Phase II, chronic, erenumab, migraine

A new treatment for chronic migraine prevention, co-developed by Novartis (NYSE: NVS) and Amgen (NASDAQ: AMGN), showed a statistically significant …

NHS promotes self-care

November 30, 2009
Sales and Marketing NHS, chronic, self care

 The NHS has run its first national week of events promoting the benefits for people in taking control of their …

The Gateway to Local Adoption Series

Latest content